Search

everythinglearnresearchcommunity

for

Search:↓

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Proper education can prevent traction alopecia in women of color.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Early treatment helps stop hair loss in women of color.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

PRP and cell therapies may help with hair loss, but more research is needed.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Lupus patients' body image issues significantly affect their mental health and need more support.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.